John Frederick de Groot

22PUBLICATIONS
242CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiological adaptationPredictive and prognostic markersSensory processes, perception and performance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 12, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.

|Apr 24, 2026
Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

|Apr 22, 2026
CERN 09-02: A phase 2 trial of carboplatin and bevacizumab for recurrent adult ependymomas.

|Apr 14, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Patrick Y Wen, Donald A Berry, Meredith B Buxton

|Mar 19, 2026
Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2+ breast cancer: TBCRC049 phase 2 study results.

Rashmi K Murthy, Barbara J O'Brien, Donald A Berry

|Mar 09, 2026
Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.

Christina Weyer-Jamora, Melissa S Brie, Paige M Bracci

Pageof 4

Frequent Collaborators

6 joint publications

Shawn L Hervey-Jumper

5 joint publications

Timothy F Cloughesy

4 joint publications

Minesh P Mehta

4 joint publications

Susan M Chang